StockUS listing USHXBMPINKHealthcareValue Trap

Helix BioMedix Inc(HXBM) Stock Analysis | Healthcare

USD --+0.00%
Reward34Low
Risk33Moderate
75%Data
Thin -125% profit margin · Revenue growing 19% YoY
USD —+0.00 (+0.00%) Previous close · PINK
Market cap 786478
Reward Ratingⓘ34 Low reward assessment · 75% data coverage
Bottom 5% of stocksView factors
Risk Ratingⓘ33 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on HXBM to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Helix BioMedix Inc?

, a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States.

AI Brief Pro

The brief on Helix BioMedix Inc

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Helix BioMedix Inc?

, a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 786.48K.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Low (34)
Company Information
SectorHealthcare
IndustryBiotechnology
Market Cap786.48K
Beta0.584
Insider Activity
12M windowNo data
No insider activity data available for this ticker.